The CRBE Summit East brings together senior drug development innovators to explore the latest advances in controlled release systems, bioavailability enhancement strategies and continuous manufacturing technologies for pharmaceutical products. Attendees benefit from technical talks, panel discussions, networking opportunities and exposure to emerging formulation and delivery solutions across the industry.

Date: May 12-13, 2026
Location: Princeton, New Jersey

JOIN US!

Discover how Catalent is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Schedule a meeting with our experts to see how we can support your next breakthrough.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President-Pharma Product Development & Head- Scientific Advisory
Date: Tuesday, May 12, 2026
Title: Innovating Oral Drug Delivery: Enabling Small and Macromolecule Therapies

The oral administration of macromolecules such as peptides and proteins continues to be limited by harsh gastrointestinal conditions, rapid enzymatic degradation, and poor membrane permeability. Novel delivery technologies—such as sophisticated lipid-based systems, delayed-release softgel platforms, and buccal or sublingual approaches—are emerging to overcome these barriers. By protecting sensitive compounds, directing site-specific release in the intestine, and leveraging lymphatic transport
pathways, these solutions aim to enhance systemic exposure. This presentation will highlight the scientific rationale and data demonstrating how these innovations are advancing the clinical feasibility of oral macromolecule delivery. The current state of macromolecule delivery and recent advances in this space will be discussed.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™